CTLA4 and neoplasm: As shown in Figures 2B–E, patients in the low KPNA2 group were markedly associated with higher levels of the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), program death-1 (PD-1), cytotoxic activity (CYT), tumor-infiltrating lymphocytes (TILs).